Edition:
United Kingdom

Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

11.70USD
16 Feb 2018
Change (% chg)

$-0.08 (-0.68%)
Prev Close
$11.78
Open
$11.78
Day's High
$11.98
Day's Low
$11.65
Volume
60,074
Avg. Vol
--
52-wk High
$12.19
52-wk Low
$9.68

Chart for

About

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Evolus Announces Pricing Of Initial Public Offering Of Common Stock

* EVOLUS, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF COMMON STOCK

08 Feb 2018

BRIEF-Evolus Inc Sees IPO Priced To Be Between $12 And $14 Per Share

* EVOLUS INC SEES IPO OF 5 MILLION SHARES PRICED TO BE BETWEEN $12 AND $14 PER SHARE – SEC FILING‍​

29 Jan 2018

Earnings vs. Estimates

No consensus analysis data available.